Kazia Therapeutics : releases final data from P2 paxalisib t

For personal use only




ASX RELEASE


3 December 2021


KAZIA ANNOUNCES POSITIVE... | December 2, 2021

Related Keywords

Australia , United States , Canada , Sydney , New South Wales , James Garner , Jane Lowe , Joe Green , Patrick Wen , Iain Ross , Genentech , Phase Of Development , Society For Neuro , Ir Department , Principal Investigator At Dana Farber Cancer Institute , Kazia Therapeutics Limited , International Towers , Kazia Therapeutics , Therapeutics Limited , Iain Ross Chairman , James Garner Chief Executive Officer , Managing Director , Principal Investigator , Dana Farber Cancer Institute , More Information , Please Contact , Orphan Drug Designation , Fast Track Designation , Rare Pediatric Disease Designation , Orphan Designation , Chief Executive Officer , Neuro Oncology Annual Meeting , Kazia Therapeutics Limited Stock Exchange , News , Information , Press Release , Or , Personal , Tse , Sx , , December , Azia , Nnounces Kza Au000000kza9 ,